| Abstract: | This study was conducted to examine the effect of endothelial cell growth supplement (ECGS) and fibroblastic growth factor (FGF) on early mammalian embryo development in vitro. Two hundred mouse blastocysts were placed randomly in culture wells containing one of five treatments: 1) Ham's F-10, 2) Ham's F-10 + 10 mug ECGS, 3) Ham's F-10 + 10 ng ECGS, 4) Ham's F-10 + 100 ng FGF and 5) Ham's F-10 + 10 ng FGF. In all cases, media were supplemented with 10% (v/v) normal steer serum. Embryos were cultured at 37 C with an atmosphere of 5% O(2), 5% CO(2) and 90% N and development was recorded at 12 h intervals for the duration of culture. The percentage of embryos that developed to expanded blastocyst (94.8), hatching blastocyst (74.4) and hatched blastocyst (71.8) in Ham's F-10 media were not different from embryos cultured in all other treatments except Ham's F-10 + 10 mug ECGS. A decrease in the percentage of embryos reaching expanded blastocyst (44.7), hatching blastocyst (23.7) and hatched blastocyst (18.4) was observed in Ham's F-10 + 10 mug ECGS. Also, a significant (P<0.01) decrease in development scores at 24, 48 and 72 h was observed for embryos cultured in Ham's F-10 + 10 mug ECGS. No difference was observed in the mean time to reach different developmental stages among treatments. The data suggest that ECGS and FGF at the doses tested have no beneficial effect on early mouse embryo development in vitro and 10 mug of ECGS has inhibitory effect. |
